Quantcast

Latest JCN Newswire Stories

2014-09-17 04:20:02

Tokyo, Sept 17, 2014 - (JCN Newswire) - Eisai Co., Ltd. announced today that a series of abstracts highlighting the latest clinical data on Halaven(R) (generic name: eribulin mesylate; non-taxane microtubule dynamics inhibitor, "Halaven") and lenvatinib mesylate (generic name; selective inhibitor of receptor tyrosine kinases (RTKs) with a novel binding mode, "lenvatinib") will be presented during the 39th European Society for Medical Oncology (ESMO) Congress...

2014-08-20 04:20:01

Eisai Submits Applications for Antiepilepsy Agent Fycompa Simultaneously In Europe and U.S. Seeking Indication Expansion as Adjunctive Treatment of Primary Generalized Tonic-Clonic Seizures Tokyo, Aug 20, 2014 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that it has submitted applications to regulatory authorities in the U.S. and Europe (the FDA and EMA respectively) for the...

2014-07-03 20:20:02

Tokyo, July 3, 2014 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that it has received approval from the European Commission of the indication expansion of Halaven (generic name: eribulin mesylate, "eribulin") to contribute to earlier treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least one chemotherapeutic regimen for advanced disease. Prior therapy should...

2014-05-27 04:20:05

Indication of Anticancer Agent Halaven for Use in Earlier-Line Treatment of Advanced Breast Cancer Tokyo, May 27, 2014 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai") announced today that its U.K. subsidiary Eisai Europe Limited has received a positive opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) on the indication expansion...

2014-05-27 04:20:02

Contains 5 Ingredients that Help Bring Out the Beauty From Within & Sodium Supplement Tokyo, May 27, 2014 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai") announced today that it will launch its new carbonated supplement drink Chocola BB Sparkling Salty Natsumikan* Flavor, classified as a Food with Nutrient Function Claims, in Japan on Monday, June 2.Chocola BB Sparkling Salty...

2014-04-25 04:20:01

LED-Based Lettuce Growth Facility Contributes to 30% Cut in Electricity Cost Tokyo, Apr 25, 2014 - (JCN Newswire) - Showa Denko (SDK) (TOKYO:4004) announces that its proprietary LED lighting equipment and high-speed plant growth technology (Shigyo Method(TM)) have been adopted by Gushiken Co., Ltd., a major bread maker in Okinawa. The company, led by President Hisao Gushiken, is headquartered in Uruma City, Okinawa Prefecture.Shigyo...

2014-02-21 04:20:02

Tokyo, Feb 21, 2014 - (JCN Newswire) - Sony Corporation today announced the development of a pico projector module equipped with Sony's independently-developed image processing system, that uses laser beam scanning (LBS)(1) to realize crisp, beautiful high-definition resolution and "focus-free" projection, regardless of the distance or angle from the projection surface. By combining this module with Wi-Fi components and a battery, it can realize a compact,...

2014-02-06 04:20:02

Tokyo, Feb 6, 2014 - (JCN Newswire) - Sony Corporation ("Sony") and Japan Industrial Partners ("JIP") today announced that they have entered into a memorandum of understanding that confirms their intent for Sony to sell to JIP Sony's PC business currently operated under the VAIO brand (the "Sale"). Sony and JIP are aiming to conclude definitive agreements by the end of March 2014, following due diligence and negotiation of detailed terms and conditions of the...

2014-02-03 04:20:02

Tokyo, Feb 3, 2014 - (JCN Newswire) - Eisai Co., Ltd. announced today that it will launch the vascular embolization device DC Bead(R) (specially controlled medical device) in Japan on February 4.DC Bead contains hydrophilic microspheres made from cross-linked polyvinyl alcohol polymer. Developed by Biocompatibles UK Limited (Biocompatibles), a BTG International group company, as an intravascular embolization device, it is injected via catheter into targeted blood...

2014-01-29 08:20:01

Tokyo, Jan 29, 2014 - (JCN Newswire) - Sony Corporation ("Sony") today announced that it will establish Sony Semiconductor Corporation ("SCK") Yamagata Technology Center ("Yamagata TEC") on March 31, 2014, utilizing the Tsuruoka Factory semiconductor-related assets held by Renesas Yamagata Semiconductor Co., Ltd. ("Renesas Yamagata Semiconductor"), which are scheduled to be transferred to Sony in accordance with the definitive agreement that Sony and Renesas...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related